tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

INZY Stock Latest News

Promising Potential of INZ-701 in Treating ENPP1 Deficiency Drives Buy Rating for Inozyme Pharma
RatingsPromising Potential of INZ-701 in Treating ENPP1 Deficiency Drives Buy Rating for Inozyme Pharma
2h ago
INZY
Inozyme announces JBMR Plus publication on ENPP1 deficiency
PremiumThe Fly
Inozyme announces JBMR Plus publication on ENPP1 deficiency
5h ago
INZY
Buy Rating on Inozyme Pharma: Promising Potential of INZ-701 and Market Opportunity
PremiumRatings
Buy Rating on Inozyme Pharma: Promising Potential of INZ-701 and Market Opportunity
2d ago
INZY
Inozyme price target lowered to $12 from $24 at Raymond James
PremiumThe Fly
Inozyme price target lowered to $12 from $24 at Raymond James
29d ago
INZY
Inozyme price target lowered to $23 from $30 at Piper Sandler
PremiumThe Fly
Inozyme price target lowered to $23 from $30 at Piper Sandler
1M ago
INZY
Inozyme Pharma Focuses on ENPP1 Deficiency Program
PremiumCompany AnnouncementsInozyme Pharma Focuses on ENPP1 Deficiency Program
1M ago
INZY
Inozyme reports prioritization of ENPP1 Deficiency program, workforce reduction
Premium
The Fly
Inozyme reports prioritization of ENPP1 Deficiency program, workforce reduction
1M ago
INZY
Inozyme sees cash runway into 1Q26
Premium
The Fly
Inozyme sees cash runway into 1Q26
1M ago
INZY
Inozyme reports FY24 EPS ($1.62), consensus ($1.51)
PremiumThe Fly
Inozyme reports FY24 EPS ($1.62), consensus ($1.51)
1M ago
INZY
Inozyme price target lowered to $30 from $43 at Piper Sandler
PremiumThe Fly
Inozyme price target lowered to $30 from $43 at Piper Sandler
3M ago
INZY
Inozyme price target lowered to $11 from $14 at Wells Fargo
PremiumThe Fly
Inozyme price target lowered to $11 from $14 at Wells Fargo
3M ago
INZY
Inozyme price target raised to $16 from $14 at H.C. Wainwright
PremiumThe Fly
Inozyme price target raised to $16 from $14 at H.C. Wainwright
3M ago
INZY
Inozyme Pharma Advances with Promising Trial Results
PremiumCompany AnnouncementsInozyme Pharma Advances with Promising Trial Results
3M ago
8K
INZY
Inozyme announces interim data from its ENERGY 1 trial, EAP on INZ-701
Premium
The Fly
Inozyme announces interim data from its ENERGY 1 trial, EAP on INZ-701
3M ago
INZY
Inozyme initiated with an Outperform at Raymond James
Premium
The Fly
Inozyme initiated with an Outperform at Raymond James
4M ago
INZY
Inozyme Pharma’s Q3 2024 Financial and Clinical Progress
PremiumCompany Announcements
Inozyme Pharma’s Q3 2024 Financial and Clinical Progress
5M ago
INZY
Inozyme reports Q3 EPS (39c), consensus (44c)
PremiumThe Fly
Inozyme reports Q3 EPS (39c), consensus (44c)
5M ago
INZY
Is INZY a Buy, Before Earnings?
PremiumPre-Earnings
Is INZY a Buy, Before Earnings?
5M ago
INZY
Inozyme Pharma Reports Promising Results in SEAPORT 1 Trial
PremiumCompany Announcements
Inozyme Pharma Reports Promising Results in SEAPORT 1 Trial
6M ago
8K
INZY
Inozyme announces ‘positive’ interim data from ongoing Phase 1 SEAPORT 1 trial
PremiumThe FlyInozyme announces ‘positive’ interim data from ongoing Phase 1 SEAPORT 1 trial
6M ago
INZY
Inozyme Pharma Welcomes New Director Erik Harris
Premium
Company Announcements
Inozyme Pharma Welcomes New Director Erik Harris
6M ago
8K
INZY
Inozyme appoints Erik Harris to board of directors
Premium
The Fly
Inozyme appoints Erik Harris to board of directors
6M ago
INZY
RARE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >